[Pathological state or cause of sarcopenia.]

Area of Science:

• Gerontology
• Muscle Physiology
• Molecular Biology

Background:

• Sarcopenia, the age-related loss of skeletal muscle mass and function, disproportionately impacts lower limbs compared to upper limbs.
• This condition differs from disuse atrophy, presenting as a gradual decline with significant involvement of fast-twitch muscle fibers.
• Aging is associated with decreased satellite cell number, impaired neuromuscular junction function, and elevated oxidative stress and chronic inflammation.

Purpose of the Study:

• To elucidate the multifactorial nature of sarcopenia.
• To identify key physiological changes contributing to age-related muscle decline.
• To understand the differential impact of aging on various muscle groups and fiber types.

Main Methods:

• Review of existing literature on sarcopenia and aging.
• Analysis of cellular and molecular mechanisms underlying muscle atrophy.
• Comparison of sarcopenia with disuse muscle atrophy.

Main Results:

• Sarcopenia exhibits a specific pattern of atrophy, favoring lower over upper limbs and anterior over posterior thigh muscles, with a faster incidence in males.
• Key aging-related changes include reduced satellite cells, declining neuromuscular junction integrity, and increased pro-inflammatory cytokines (e.g., IL-6, TNF-α).
• Muscle protein breakdown is upregulated via ubiquitin-dependent proteolysis, while oxidative stress contributes to mitochondrial dysfunction and apoptosis.

Conclusions:

• Sarcopenia is a complex process influenced by reduced anabolic factors (e.g., IGF-1, sex hormones, vitamin D) and increased catabolic pathways.
• Understanding these mechanisms is crucial for developing interventions to combat age-related muscle loss.
• Targeting satellite cells, neuromuscular function, inflammation, and protein synthesis pathways may offer therapeutic strategies.